{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:55:18Z","timestamp":1785351318772,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metabolic dysfunction-associated steatohepatitis (MASH) can progress to liver cirrhosis, increasing mortality risk. The study investigates the role of ferroptosis\u2014an inflammatory cell death mechanism\u2014in MASH and evaluates the therapeutic effects of mitoglitazone and proanthocyanidin in targeting ferroptosis to mitigate MASH progression. Forty male albino mice were divided into five groups (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20098): normal control (NC) fed a standard chow diet and given 2% DMSO; MASH group was maintained on MASH protocol (high fructose-high fat diet); mitoglitazone (Mito) group was kept on MASH protocol and given Mito (10\u00a0mg\/kg\/day); proanthocyanidin (Pro) group was kept on MASH protocol and given Pro (150\u00a0mg\/kg\/day); Mito\u2009+\u2009Pro co-treated group was given Mito and Pro parallel with MASH protocol, all treatments for 12\u00a0weeks. MASH induction significantly (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) increased liver weight, liver index, serum liver enzymes (ALT &amp; AST), serum glucose, insulin, insulin resistance (HOMA-IR), lipid profile (total cholesterol, triglycerides, LDL-C), ferroptosis biomarkers (total iron, soluble transferrin receptor-1 (sTfR1), and expression of liver acyl-CoA synthetase long-chain family member 4 (ACSL4) with diffused macrovesicular severe steatosis, and inflammatory cells infiltration in liver tissues compared to NC. However, HDL-cholesterol, ferroptosis biomarkers (liver glutathione peroxidase X4 (GPX4), and total glutathione peroxidase (GPX) activities and glutathione (GSH) content) were reduced significantly (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) in MASH group compared to NC. On the other hand, Mito, Pro, and their combination significantly improved ferroptotic biomarkers (GSH, GPX4, sTFR1, and total iron and ACSL-4 gene expression), glucose homeostasis, lipid profile, liver enzymes, and histology compared to MASH group. Combining the insulin-sensitizing properties with targeting of ferroptosis, by the co-treatment with mitoglitazone (MSDC-0160) and proanthocyanidin, could be beneficial in inhibition of lipogenesis with retardation of MASH development in mice.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00210-025-04271-z","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:26:47Z","timestamp":1747643207000},"page":"15825-15836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1007","volume":"398","author":[{"given":"Sohair M. Abd","family":"El-Naby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-8940","authenticated-orcid":false,"given":"Naglaa F.","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-8147","authenticated-orcid":false,"given":"Nahla E.","family":"El-Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8669-4466","authenticated-orcid":false,"given":"Amera O.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"issue":"3","key":"4271_CR1","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1002\/j.2040-4603.2022.tb00226.x","volume":"12","author":"MK Ameka","year":"2022","unstructured":"Ameka MK, Hasty AH (2022) Paying the iron price: Liver iron homeostasis and metabolic disease. Compr Physiol 12(3):3641\u20133663","journal-title":"Compr Physiol"},{"key":"4271_CR2","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882\u20138","journal-title":"J Lab Clin Med"},{"issue":"3","key":"4271_CR3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/jcm.28.3.495-503.1990","volume":"28","author":"R Boom","year":"1990","unstructured":"Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J (1990) Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28(3):495\u2013503","journal-title":"J Clin Microbiol"},{"issue":"8","key":"4271_CR4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/biom10081162","volume":"10","author":"JL Buchanan","year":"2020","unstructured":"Buchanan JL, Taylor EB (2020) Mitochondrial pyruvate carrier function in health and disease across the lifespan. Biomolecules 10(8):1162","journal-title":"Biomolecules"},{"issue":"5","key":"4271_CR5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/clinchem\/19.5.476","volume":"19","author":"G Bucolo","year":"1973","unstructured":"Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19(5):476\u2013482","journal-title":"Clin Chem"},{"issue":"1","key":"4271_CR6","first-page":"147","volume":"43","author":"J Cheng","year":"2020","unstructured":"Cheng J, Fan YQ, Liu BH, Zhou H, Wang JM, Chen QX (2020) ACSL4 suppresses glioma cells proliferation via activating ferroptosis. Oncol Rep 43(1):147\u2013158","journal-title":"Oncol Rep"},{"key":"4271_CR7","doi-asserted-by":"publisher","unstructured":"Cheng Z, Chu H, Zhu Q, Yang L (2023) Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications. Front Nutr [Internet]. 2023 Mar 13 [cited 2024 Mar 12];10. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fnut.2023.1090338","DOI":"10.3389\/fnut.2023.1090338"},{"issue":"4","key":"4271_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0009-9120(00)00071-0","volume":"33","author":"F Cotton","year":"2000","unstructured":"Cotton F, Thiry P, Boeynaems J (2000) Measurement of soluble transferrin receptor by immunoturbidimetry and immunonephelometry. Clin Biochem 33(4):263\u2013267","journal-title":"Clin Biochem"},{"issue":"9","key":"4271_CR9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/1440-1681.12446","volume":"42","author":"NE El-Ashmawy","year":"2015","unstructured":"El-Ashmawy NE, El-Bahrawy HA, Shamloula MM, Ibrahim AO (2015) Antifibrotic effect of AT-1 blocker and statin in rats with hepatic fibrosis. Clin Exp Pharmacol Physiol 42(9):979\u2013987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4271_CR10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biopha.2018.10.049","volume":"109","author":"NE El-Ashmawy","year":"2019","unstructured":"El-Ashmawy NE, Al-Ashmawy GM, Kamel AA (2019) Docosahexaenoic acid-flurbiprofen combination ameliorates metaflammation in rats fed on high-carbohydrate high-fat diet. Biomed Pharmacother Biomed Pharmacother 109:233\u2013241","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"4271_CR11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0076-6879(84)05015-1","volume":"105","author":"L Floh\u00e9","year":"1984","unstructured":"Floh\u00e9 L, G\u00fcnzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114\u2013121","journal-title":"Methods Enzymol"},{"issue":"6","key":"4271_CR12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"4","key":"4271_CR13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","volume":"1","author":"A Gastaldelli","year":"2019","unstructured":"Gastaldelli A, Cusi K (2019) From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options. JHEP Rep Innov Hepatol 1(4):312\u2013328","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"368","key":"4271_CR14","doi-asserted-by":"crossref","first-page":"368ra174","DOI":"10.1126\/scitranslmed.aag2210","volume":"8","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z et al (2016) Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson\u2019s disease. Sci Transl Med. 8(368):368ra174","journal-title":"Sci Transl Med."},{"issue":"8","key":"4271_CR15","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.21037\/tcr-21-2157","volume":"11","author":"N Guo","year":"2022","unstructured":"Guo N (2022) Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma. Transl Cancer Res 11(8):2688","journal-title":"Transl Cancer Res"},{"issue":"23","key":"4271_CR16","first-page":"8644","volume":"26","author":"AO Hamouda","year":"2022","unstructured":"Hamouda AO, Abdel-Hamed AR, Abo-Elmatty DM, Khedr NF, Ghattas MH (2022) Pentoxifylline and its association with kaempferol improve NASH-associated manifestation in mice through anti-apoptotic, anti-necroptotic, antioxidant, and anti-inflammatory mechanisms. Eur Rev Med Pharmacol Sci 26(23):8644\u20138659","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"42","key":"4271_CR17","doi-asserted-by":"crossref","first-page":"e4947","DOI":"10.1097\/MD.0000000000004947","volume":"95","author":"L He","year":"2016","unstructured":"He L, Liu X, Wang L, Yang Z (2016) Thiazolidinediones for nonalcoholic steatohepatitis: a meta-analysis of randomized clinical trials. Medicine (Baltimore) 95(42):e4947","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"4271_CR18","doi-asserted-by":"crossref","first-page":"1184280","DOI":"10.3389\/fendo.2023.1184280","volume":"25","author":"L He","year":"2023","unstructured":"He L, Wang J, Tao B, Zhu R, Li C, Ning B (2023) Identification of ferroptosis-related genes in the progress of NASH. Front Endocrinol 25(14):1184280","journal-title":"Front Endocrinol"},{"issue":"3","key":"4271_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K et al (2018) Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172(3):409-422.e21","journal-title":"Cell"},{"issue":"12","key":"4271_CR20","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.3390\/ijms241210021","volume":"24","author":"B Jia","year":"2023","unstructured":"Jia B, Li J, Song Y, Luo C (2023) ACSL4-mediated ferroptosis and its potential role in central nervous system diseases and injuries. Int J Mol Sci 24(12):10021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4271_CR21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatol Baltim Md 41(6):1313\u20131321","journal-title":"Hepatol Baltim Md"},{"issue":"13","key":"4271_CR22","first-page":"910292","volume":"29","author":"FJ Li","year":"2022","unstructured":"Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC (2022) System Xc \u2212\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 29(13):910292","journal-title":"Front Pharmacol"},{"issue":"2","key":"4271_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000502235","volume":"13","author":"M Liu","year":"2020","unstructured":"Liu M, Yun P, Hu Y, Yang J, Khadka RB, Peng X (2020) Effects of grape seed proanthocyanidin extract on obesity. Obes Facts 13(2):279\u2013291","journal-title":"Obes Facts"},{"issue":"10","key":"4271_CR24","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184(10):2537\u20132564","journal-title":"Cell"},{"issue":"314","key":"4271_CR25","doi-asserted-by":"crossref","first-page":"121279","DOI":"10.1016\/j.lfs.2022.121279","volume":"1","author":"YW Lv","year":"2023","unstructured":"Lv YW, Du Y, Ma SS, Shi YC, Xu HC, Deng L et al (2023) Proanthocyanidins attenuates ferroptosis against influenza-induced acute lung injury in mice by reducing IFN-\u03b3. Life Sci 1(314):121279","journal-title":"Life Sci"},{"issue":"8","key":"4271_CR26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/antiox10081229","volume":"10","author":"G Mannino","year":"2021","unstructured":"Mannino G, Chinig\u00f2 G, Serio G, Genova T, Gentile C, Munaron L et al (2021) Proanthocyanidins and where to find them: a meta-analytic approach to investigate their chemistry, biosynthesis, distribution, and effect on human health. Antioxidants 10(8):1229","journal-title":"Antioxidants"},{"issue":"7","key":"4271_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419","journal-title":"Diabetologia"},{"issue":"5","key":"4271_CR28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.29025","volume":"65","author":"KS McCommis","year":"2017","unstructured":"McCommis KS, Hodges WT, Brunt EM, Nalbantoglu ILK, McDonald WG, Holley C et al (2017) Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatol Baltim Md 65(5):1543\u201356","journal-title":"Hepatol Baltim Md"},{"issue":"133","key":"4271_CR29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.freeradbiomed.2018.07.006","volume":"1","author":"K Miyanishi","year":"2019","unstructured":"Miyanishi K, Tanaka S, Sakamoto H, Kato J (2019) The role of iron in hepatic inflammation and hepatocellular carcinoma. Free Radic Biol Med 1(133):200\u2013205","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"4271_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12935-021-02366-0","volume":"22","author":"Q Nie","year":"2022","unstructured":"Nie Q, Hu Y, Yu X, Li X, Fang X (2022) Induction and application of ferroptosis in cancer therapy. Cancer Cell Int 22(1):12","journal-title":"Cancer Cell Int"},{"key":"4271_CR31","doi-asserted-by":"publisher","unstructured":"Peleman C, Francque S, Berghe TV (2024) Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation. EBioMedicine 102:105088. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105088","DOI":"10.1016\/j.ebiom.2024.105088"},{"issue":"1\u20132","key":"4271_CR32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2007.04.008","volume":"382","author":"CM Pfeiffer","year":"2007","unstructured":"Pfeiffer CM, Cook JD, Mei Z, Cogswell ME, Looker AC, Lacher DA (2007) Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta Int J Clin Chem 382(1\u20132):112\u2013116","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"1","key":"4271_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W et al (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22(1):63","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"4271_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","volume":"190","author":"J Qi","year":"2020","unstructured":"Qi J, Kim JW, Zhou Z, Lim CW, Kim B (2020) Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation\u2013mediated cell death in mice. Am J Pathol 190(1):68\u201381","journal-title":"Am J Pathol"},{"issue":"465","key":"4271_CR35","doi-asserted-by":"crossref","first-page":"116440","DOI":"10.1016\/j.taap.2023.116440","volume":"15","author":"Y Qi","year":"2023","unstructured":"Qi Y, Hu M, Qiu Y, Zhang L, Yan Y, Feng Y et al (2023) Mitoglitazone ameliorates renal ischemia\/reperfusion injury by inhibiting ferroptosis via targeting mitoNEET. Toxicol Appl Pharmacol 15(465):116440","journal-title":"Toxicol Appl Pharmacol"},{"key":"4271_CR36","doi-asserted-by":"crossref","first-page":"108999","DOI":"10.1016\/j.biopha.2019.108999","volume":"116","author":"A Rauf","year":"2019","unstructured":"Rauf A, Imran M, Abu-Izneid T, Patel S, Pan X, Naz S, Suleria HAR (2019) Proanthocyanidins: a comprehensive review. Biomed Pharmacother 116:108999","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4271_CR37","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatol Baltim Md 78(6):1966\u20131986","journal-title":"Hepatol Baltim Md"},{"issue":"10","key":"4271_CR38","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/nu11102435","volume":"11","author":"C Rodr\u00edguez-P\u00e9rez","year":"2019","unstructured":"Rodr\u00edguez-P\u00e9rez C, Garc\u00eda-Villanova B, Guerra-Hern\u00e1ndez E, Verardo V (2019) Grape seeds proanthocyanidins: an overview of in vivo bioactivity in animal models. Nutrients 11(10):2435","journal-title":"Nutrients"},{"issue":"5","key":"4271_CR39","doi-asserted-by":"crossref","first-page":"e62012","DOI":"10.1371\/journal.pone.0062012","volume":"8","author":"N Rohatgi","year":"2013","unstructured":"Rohatgi N, Aly H, Marshall CA, McDonald WG, Kletzien RF, Colca JR et al (2013) Novel insulin sensitizer modulates nutrient sensing pathways and maintains \u03b2-cell phenotype in human islets. PLoS ONE 8(5):e62012","journal-title":"PLoS ONE"},{"issue":"5","key":"4271_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/2230-8210.163172","volume":"19","author":"D Sanyal","year":"2015","unstructured":"Sanyal D, Mukherjee P, Raychaudhuri M, Ghosh S, Mukherjee S, Chowdhury S (2015) Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab 19(5):597\u2013601","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"4271_CR41","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101\u20131108","journal-title":"Nat Protoc"},{"key":"4271_CR42","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopha.2017.07.039","volume":"93","author":"AA Sherif","year":"2017","unstructured":"Sherif AA, Abdelhalim SZ, Salim EI (2017) Immunohistochemical and biochemical alterations following administration of proanthocyanidin extract in rats hepatocellular carcinoma. Biomed Pharmacother Biomedecine Pharmacother 93:1310\u20131319","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"3","key":"4271_CR43","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","volume":"130","author":"GI Smith","year":"2020","unstructured":"Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW et al (2020) Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest 130(3):1453\u20131460","journal-title":"J Clin Invest"},{"issue":"39","key":"4271_CR44","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.3748\/wjg.v21.i39.11077","volume":"21","author":"P St\u00e5l","year":"2015","unstructured":"St\u00e5l P (2015) Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World J Gastroenterol 21(39):11077\u201311087","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4271_CR45","first-page":"1","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zheng Y, Wang C, Liu Y (2018) Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis 9(7):1\u201315","journal-title":"Cell Death Dis"},{"issue":"1","key":"4271_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J, Wang F, Min J (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8(1):1\u201330","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"4271_CR47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jcp.22.2.158","volume":"22","author":"P Trinder","year":"1969","unstructured":"Trinder P (1969) Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 22(2):158\u2013161","journal-title":"J Clin Pathol"},{"issue":"6","key":"4271_CR48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","volume":"10","author":"S Tsurusaki","year":"2019","unstructured":"Tsurusaki S, Tsuchiya Y, Koumura T, Nakasone M, Sakamoto T, Matsuoka M et al (2019) Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. Cell Death Dis 10(6):449","journal-title":"Cell Death Dis"},{"issue":"152","key":"4271_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"20","author":"F Ursini","year":"2020","unstructured":"Ursini F, Maiorino M (2020) Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med 20(152):175\u2013185","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"4271_CR50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/jcp.25.11.940","volume":"25","author":"JH Wilkinson","year":"1972","unstructured":"Wilkinson JH, Baron DN, Moss DW, Walker PG (1972) Standardization of clinical enzyme assays: a reference method for aspartate and alanine transaminases. J Clin Pathol 25(11):940\u2013944","journal-title":"J Clin Pathol"},{"issue":"2","key":"4271_CR51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj0680197","volume":"68","author":"ID Wootton","year":"1958","unstructured":"Wootton ID (1958) Determination of iron in biological material by spectrophotometry of ferric perchlorate. Biochem J 68(2):197\u2013199","journal-title":"Biochem J"},{"issue":"1","key":"4271_CR52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, Lei P (2021) Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther 6(1):49","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4271_CR53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/nutrit\/nux028","volume":"75","author":"K Yang","year":"2017","unstructured":"Yang K, Chan CB (2017) Proposed mechanisms of the effects of proanthocyanidins on glucose homeostasis. Nutr Rev 75(8):642\u2013657","journal-title":"Nutr Rev"},{"issue":"10","key":"4271_CR54","doi-asserted-by":"crossref","first-page":"e10896","DOI":"10.1016\/j.heliyon.2022.e10896","volume":"8","author":"I Yustisia","year":"2022","unstructured":"Yustisia I, Tandiari D, Cangara MH, Hamid F, Daud NA (2022) A high-fat, high-fructose diet induced hepatic steatosis, renal lesions, dyslipidemia, and hyperuricemia in non-obese rats. Heliyon 8(10):e10896","journal-title":"Heliyon"},{"issue":"9","key":"4271_CR55","doi-asserted-by":"crossref","first-page":"961892","DOI":"10.3389\/fnut.2022.961892","volume":"11","author":"L Zhang","year":"2022","unstructured":"Zhang L, Dai X, Wang L, Cai J, Shen J, Shen Y et al (2022) Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease. Front Nutr 11(9):961892","journal-title":"Front Nutr"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04271-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04271-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T11:13:51Z","timestamp":1761304431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04271-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4271"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04271-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the guidelines for the care and use of laboratory animals approved by Research Ethical Committee, Faculty of Pharmacy, Tanta University, Egypt (Approval No.; TP\/RE\/7\/23 M-0029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It is available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}